Remove Algorithm Remove Analysis Remove Competitive Landscape Remove Due Diligence
article thumbnail

Venture Capital in the Age of AI: Transforming Due Diligence

Alpha Sense BI

On the AlphaSense platform, this reality rings true as we noticed an over 50% increase in documents mentioning “due diligence” over the past year. Once an arduous and time-consuming task, the dawn of artificial intelligence (AI) and generative AI (genAI) has transformed the way venture capital investors conduct due diligence.

article thumbnail

Competitive Intelligence Experts Discuss Effectiveness of AI Tools During ArchIntel’s AI in CI Virtual Event

ArchIntel

August Jackson , senior director of Market and Competitive Intelligence with Deltek , moderated the panel after delivering his opening address, where he analyzed the competitive landscape as technology continues to evolve. . He stated that AI has, and will continue, to influence competitive intelligence in two ways. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Traditional due diligence for start-up investors has historically been riddled with inefficiencies—tying up resources to sort through countless documents and copious amounts of data, and manually crafting market comparisons and performance. Forecasting Analysis : Analyze financial data to generate potential forecasts.

Capital 52
article thumbnail

How to Conduct Consumer and Retail Market Research

Alpha Sense BI

To stay competitive in the current economic climate , companies need to conduct comprehensive and efficient market research. Likewise, executive leadership must have a thorough understanding of the competitive landscape they are operating in while staying keenly aware of evolving consumer trends. Try this feature for free here.

article thumbnail

AI in Biopharma: Use Cases and Considerations

Alpha Sense BI

Through the use of complex algorithms , AI sifts through large datasets , identifying potential drug candidates and biomarkers much swifter than by manual means. Further, AI’s predictive modeling algorithms refine drug target validation, thus reducing the attrition rates during the expensive clinical testing phases.